IPO-bound Anthem Biosciences to invest ₹154 cr towards expansion of custom synthesis and fermentation capacities

The ₹3,395 crore IPO of Bengaluru-based Anthem Biosciences Ltd will open on July 14 and close on July 16
| Photo Credit:
cueapi

IPO-bound contract research, development, and manufacturing organisation (CRDMO), Anthem Biosciences Ltd has earmarked ₹154 crore towards the expansion of custom synthesis and fermentation capacities at its facilities in Karnataka. This follows a capital expenditure of ₹314 crore in FY25 for acquiring property, plant, and laboratory equipment, with a capital work-in-progress (CWIP) of approximately ₹300 crore as of FY25.

Expansion plans

Founded in 2006, the company has two operational manufacturing facilities in India, Unit I (Bommassandra) and Unit II (Harohalli), both in Karnataka, with an aggregate annual custom synthesis capacity of 270 kl (kilolitre) and fermentation capacity of 142 kl, as of March 31, 2025. 

The company’s expansion plans include increasing custom synthesis capacity at Unit II by 130 kl and adding 25 kl of custom synthesis and 40 kl of fermentation capacity at a new Unit III. Both projects are expected to be operational by the first half of FY26

Post-expansion, the aggregate annual custom synthesis capacity and fermentation capacity are expected to increase to 425 kl and 182 kl, respectively.

Anthem has also acquired land parcels which it intends to use for future capacity expansion, including Unit IV (where phase-wise construction work has commenced), and the proposed Unit V facility. It expects to fund future capital expenditures primarily using cash generated from its operations and/or debt financing, including bank loans.

The ₹3,395 crore IPO of Bengaluru-based Anthem Biosciences Ltd will open on July 14 and close on July 16, its RHP showed. The one-day bidding for anchor investors is scheduled for July 11, the company said. The price band has been set at ₹540 – ₹570, with an indicative market cap of ₹32,000 crore.

On the financial front, the company’s revenue from operations increased 30 per cent to ₹1,844 crore in FY25 from ₹1,419 crore in FY24. The PAT for the year ended March 31, 2025, was ₹451 crore, a jump of 23 per cent over FY24.

(With inputs from bl intern Nethra Sailesh)

Published on July 11, 2025